HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oropharyngeal cancer pathogenesis: ubiquitin proteolytic, apoptotic and epidermal growth factor related pathways act in concert--first report.

Abstract
The current study was carried out to examine the clinical characteristics and survival-probability rates of 51 patients treated for oral (tongue) cancer and to correlate it with various tumor markers. The clinical data and survival probability rates were correlated with the immunohistological analysis of p27, Skp2, p53, Bcl-2, TUNEL (apoptotic rate) and c-erbB-2 markers. The 5-year survival-probability correlated with staging, grading and base of tongue location. An inverse relation between the expression of p27 and Skp2, p27 and grading, and a direct relation between Skp2 and grading were demonstrated. Concomitantly, significant correlations between low p27, high Skp2 and high TUNEL (apoptotic rate) expressions and between low p27 and high c-erbB-2 (Her2) expressions in the cancer lesions were demonstrated. The accumulated data may be employed in the future for a better understanding of the biology behind oral cancer and for developing better means of detection and treatment.
AuthorsOfer Ben-Izhak, Fares Kablan, Zvi Laster, Rafael M Nagler
JournalOral oncology (Oral Oncol) Vol. 41 Issue 8 Pg. 851-60 (Sep 2005) ISSN: 1368-8375 [Print] England
PMID16043384 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • S-Phase Kinase-Associated Proteins
  • Tumor Suppressor Protein p53
  • Ubiquitin
  • Cyclin-Dependent Kinase Inhibitor p27
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor (metabolism)
  • Carcinoma, Squamous Cell (diagnosis, genetics, metabolism)
  • Cyclin-Dependent Kinase Inhibitor p27 (metabolism)
  • Female
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • S-Phase Kinase-Associated Proteins (metabolism)
  • Survival Analysis
  • Tongue Neoplasms (diagnosis, genetics, metabolism)
  • Tumor Suppressor Protein p53 (metabolism)
  • Ubiquitin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: